Use of interleukin-22 as a biomarker of resistance to hiv...

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 38/00 (2006.01)

Patent

CA 2544972

The invention relates to the use as biomarkers of resistance to infections in humans of one or several agonists of the formyl peptide receptors (FPR) receptors family and formyl peptide receptors-like 1 (FPRL1). Said biomarkers are useful in diagnostics, prophylaxis and therapeutics.

L'invention concerne l'utilisation de biomarqueurs de résistance aux infections chez l'homme, d'un ou de nombreux agonistes de la famille des récepteurs de récepteurs de peptide formyle (FPR) et de récepteurs de peptide de formyle de type 1 (FPRL1). Lesdits biomarqueurs s'utilisent dans des applications diagnostiques, prophylactiques et thérapeutiques.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Use of interleukin-22 as a biomarker of resistance to hiv... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Use of interleukin-22 as a biomarker of resistance to hiv..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of interleukin-22 as a biomarker of resistance to hiv... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-2091227

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.